Psoriasis: Latest

Fast Five Quiz: The Psychosocial Burden of Psoriasis Are you up to date with the psychosocial burden of psoriasis? Test your knowledge with this quick quiz.
Medscape, January 04, 2024
Experimental Topical Drug Shows Promise for AD, Psoriasis In the phase 2 study, researchers at 34 sites in four countries randomized 104 patients with mild to moderate AD or psoriasis to receive the topical PDE4 inhibitor or a vehicle once daily for 6 weeks.
MDedge News, January 04, 2024

2
Fast Five Quiz: Multiple Sclerosis Comorbidities Are you aware of the ways that comorbidities might affect patients with multiple sclerosis, including diagnosis, disability progression, and treatment options? Test your knowledge with this quick quiz.
Medscape, January 02, 2024
Keeping Injectable Products in Cosmetic Dermatology Safe The rapid increase in intradermal injections of hyaluronic acid and Botox has been accompanied by an increase in side effects.
Medscape Medical News, December 26, 2023
Paradoxical Eczema Risk Low With Biologic Psoriasis Tx Ali Al-Janabi, MA, and associates found that 273 (1%) of approximately 25,000 drug exposures in 13,699 biologic-treated patients with psoriasis were associated with paradoxical eczema.
MDedge News, December 22, 2023
Reducing CVD Morbidity and Mortality in Psoriasis and PsA Only a minority of patients with psoriatic disease know about their increased risks.
MDedge News, December 20, 2023

1
Alert Roflumilast Foam Gets Nod for Seborrheic Dermatitis Patients in the roflumilast group showed significant improvements in all secondary endpoints, including itching, scaling, and erythema.
MDedge News, December 18, 2023
When to Initiate Systemic Treatment for Plaque Psoriasis Dr Abby S. Van Voorhees discusses the optimal time to initiate systemic treatment for plaque psoriasis as well as key factors in the choice of systemic therapy and when earlier use may be beneficial.
Medscape, December 14, 2023
Bimekizumab Promising for Palmoplantar Pustular Psoriasis PPP is a type of pustular psoriasis that remains a treatment challenge, and available treatments for palmoplantar plaque psoriasis with pustules also "remain unsatisfactory."
MDedge News, December 12, 2023

1
Tape Strips Detect Hidradenitis Suppurativa Biomarkers "Tape strips can provide important clues to when and which drugs to use in HS in patients with both early and late disease, which can change clinical practice."
MDedge News, December 08, 2023
How to Develop a Patient Referral Program Dr Joseph Eastern discusses the revenue and growth that a patient referral program can bring to your private practice – and what to do when you're ready for this step.
MDedge, December 08, 2023
Patients With hEDS Report Skin Laxity, Scarring Follicular occlusion, mast cell disease, and eczema were common presentations among patients with hypermobile Ehlers-Danlos syndrome.
MDedge News, December 07, 2023

2
Axial Spondyloarthritis Highlights From ACR 2023 Key data on axial spondyloarthritis (axSpA) from ACR 2023 include efficacy of intravenous secukinumab, effect of long-term NSAID use, and referral recommendations for patients with suspected axSpA.
Medscape, December 06, 2023
Analysis Supports Link Between Psoriasis and OSA Several hypotheses may explain the connection, such as the presence of inflammatory mediators and nocturnal cytokine secretion, according to the authors.
Medscape Medical News, December 04, 2023
MSWS 2023 Misdiagnoses Among Challenges in Managing Cutaneous Lymphoma Although predictive tools to identify those at risk of disease progression are in their infancy, the development of such tools is crucial for improving patient outcomes.
Medscape Medical News, December 02, 2023
Nail Psoriasis in Black Patients Often Overlooked Underrepresentation of Black patients with psoriasis in trials and textbooks might partially explain why clinicians are slow to recognize nail involvement, even after psoriasis has been diagnosed.
MDedge News, November 28, 2023
HS: Positive Results Reported With Anti-IL17A/F Therapies One of the trials evaluated a nanobody inhibitor, sonelokimab, a molecule with a substantially smaller size than traditional monoclonal antibodies.
MDedge News, November 28, 2023
A Pill for Psoriasis: The Latest Oral Medications Kylee Wang and Dr Jennifer Soung give an overview of the current oral therapies for psoriasis, plus a look at potential new agents.
Medscape Dermatology, November 28, 2023
Parent Concerns a Factor When Treating Patients With AD For a parent whose child has an inflammatory skin disease, pigmentation changes, rather than inflammation, might be the reason that he or she brought the child to the clinician.
MDedge News, November 23, 2023

1
ACR 2023 IV Secukinumab Trials Hit Primary Endpoints in PsA, AxSpA Two phase 3 trials of the recently approved IV formulation of secukinumab showed its efficacy vs placebo in treating psoriatic arthritis and axial spondyloarthritis.
MDedge News, November 20, 2023
ACR 2023 First Referral Guide Issued for Axial Spondyloarthritis The draft recommendations are a 'good first step,' but more awareness around axial spondyloarthritis in the non-rheumatology community is also needed to improve diagnosis, one expert said.
Medscape Medical News, November 15, 2023

3
ACR 2023 Apremilast Beats Placebo in Early PsA Affecting Few Joints Oligoarticular PsA can significantly affect quality of life even though few joints are affected, and there's a lack of relevant clinical data to guide treatment.
MDedge News, November 15, 2023
AAD Updates Guidelines for Managing AD The guidelines cover approved and off-label uses of systemic therapies and phototherapy, including new treatments that have become available since the last guidelines were published in 2014.
MDedge News, November 13, 2023
ACR 2023 TNF Blockers Not Associated With Poorer Pregnancy Outcomes Patients with rheumatic disease who continued TNF blockers during their pregnancy did not have an increased risk of worse fetal and maternal outcomes and had a lower risk of severe infection.
Medscape Medical News, November 13, 2023
Palmoplantar Pustulosis: Treatment Challenges When it comes to pustular disease localized to the hands and feet, treatment options have only modest efficacy, according to speakers at the annual National Psoriasis Foundation research symposium.
MDedge News, November 13, 2023
Teasing Apart Multiple Biologic Failure in Psoriasis, PsA 'Tough-to-treat psoriasis remains a challenge despite newer therapies ... Why do we still have this sub-population of patients who seem to be refractory?'
MDedge News, November 08, 2023
Ready to Start Engaging on Social Media? In the opinion of Swati Kannan, MD, deciding whether or not to establish a presence on social media starts with a gut-check about your intentions.
MDedge News, November 03, 2023
Shingles Prevention in Immunocompromised Dermatology Patients Many immunomodulatory medications used in dermatology can increase the risk of herpes zoster. Review the use of the recombinant zoster vaccine in patients receiving these drugs.
Skin Therapy Letter, November 03, 2023
Alert FDA Approves First Ustekinumab Biosimilar The drug has also been granted an interchangeability designation and has been approved for six indications.
Medscape Medical News, November 01, 2023

No Results